Inventor · disambiguated record
Guillaume Dutheuil
Also filed as: DUTHEUIL GUILLAUME
22 granted patents·7 pending applications·55 citations·filing 2008–2024
93Inventor score
Top patents by PatentIndex Score
29 records- 0195US9422299B2Substituted [1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonistsEUROSCREEN SA·Filed 2015·Granted Aug 23, 2016·17 cites·30 claims
- 0291US8871761B2NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disordersEUROSCREEN SA·Filed 2012·Granted Oct 28, 2014·15 cites·12 claims
- 0385US9987274B2N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonistsOGEDA SA·Filed 2016·Granted Jun 5, 2018·4 cites·19 claims
- 0484US10787458B2Chiral synthesis of N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-A]pyrazinesOGEDA SA·Filed 2019·Granted Sep 29, 2020·2 cites·14 claims
- 0583US9475814B2Chiral N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereofEUROSCREEN SA·Filed 2012·Granted Oct 25, 2016·7 cites·20 claims
- 0682US10836768B2N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonistsOGEDA SA·Filed 2018·Granted Nov 17, 2020·1 cites·12 claims
- 0782US2024199618A1NOVEL N-ACYL-[3-SUBSTITUTED]-[8-SUBSTITUTED]-5,6-DIHYDRO-[1,2,4]TRIAZOLO[4,3-a]PYRAZINES AS SELECTIVE NK-3 RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITION, METHODS FOR USE IN NK-3 RECEPTOR-MEDIATED DISORDERSOGEDA SA·Filed 2023·Application pending·0 cites
- 0881US10183948B2N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonistsOGEDA SA·Filed 2017·Granted Jan 22, 2019·1 cites·13 claims
- 0979US9969745B2N-acyl-(3-substituted)-(8-methyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor-mediated disordersOGEDA SA·Filed 2017·Granted May 15, 2018·2 cites·11 claims
- 1077US10065961B2Chiral N-acyl-5,6,7,(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereofEUROSCREEN SA·Filed 2016·Granted Sep 4, 2018·2 cites·5 claims
- 1176US9969738B2N-acyl-(3-substituted)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor-mediated disordersEUROSCREEN SA·Filed 2014·Granted May 15, 2018·2 cites·9 claims
- 1274US10683295B2Chiral N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-A]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereofOGEDA SA·Filed 2018·Granted Jun 16, 2020·1 cites·5 claims
- 1373US11731974B2N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonistsOGEDA SA·Filed 2020·Granted Aug 22, 2023·0 cites·8 claims
- 1473US10030025B2Substituted [1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonistsEUROSCREEN SA·Filed 2016·Granted Jul 24, 2018·1 cites·19 claims
- 1567US10941151B2Chiral N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereofOGEDA SA·Filed 2020·Granted Mar 9, 2021·0 cites·4 claims
- 1666US12091400B2Piperidine derivatives as METTL3 inhibitorsEPICS THERAPEUTICS·Filed 2024·Granted Sep 17, 2024·0 cites·17 claims
- 1766US2025002475A1Piperidine derivatives as mettl3 inhibitorsEPICS THERAPEUTICS·Filed 2024·Application pending·0 cites
- 1865US2024294472A1Polymorphs of (2s,5r)-5-(2-chlorophenyl)-1-(2'-methoxy-[1,1'-biphenyl]-4-carbonyl)pyrrolidine-2-carboxylic acid and preparation processes thereofEPICS THERAPEUTICS·Filed 2024·Application pending·0 cites
- 1964US12054457B2Polymorphs of (2S,5R)-5-(2-chlorophenyl)-1-(2′-methoxy-[1,1′-biphenyl]-4-carbonyl)pyrrolidine-2-carboxylic acid and preparation processes thereofEPICS THERAPEUTICS·Filed 2023·Granted Aug 6, 2024·0 cites·15 claims
- 2064US2020125564A1Novel nk-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in nk-3 receptors mediated disordersOGEDA SA·Filed 2019·Application pending·0 cites
- 2161US9926325B2NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disordersOGEDA SA·Filed 2014·Granted Mar 27, 2018·0 cites·4 claims
- 2259US10544150B2NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disordersOGEDA SA·Filed 2018·Granted Jan 28, 2020·0 cites·12 claims
- 2358US9840508B2N-acyl-(3-substituted)-(8-methyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a] pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor-mediated disordersEUROSCREEN SA·Filed 2014·Granted Dec 12, 2017·0 cites·12 claims
- 2454US12162849B2Synthesis of 3-methyl-1,2,4-thiadiazole-5-carbohydrazide or of the methyl-d3 deuterated form thereofOGEDA SA·Filed 2019·Granted Dec 10, 2024·0 cites·17 claims
- 2552US10214533B2N-acyl-(3-substituted)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor-mediated disordersOGEDA SA·Filed 2018·Granted Feb 26, 2019·0 cites·9 claims
- 2651US2011230477A1Compounds, pharmaceutical composition and methods for use in treating metabolic disordersEUROSCREEN SA·Filed 2009·Application pending·0 cites
- 2750US2017298070A1Novel chiral synthesis of n-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazinesOGEDA SA·Filed 2015·Application pending·0 cites
- 2843US2009048291A1Novel Piperidine-4-Acetic Acid Derivatives and Their UseEUROSCREEN SA·Filed 2008·Application pending·0 cites
- 2936US10065960B2NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disordersOGEDA SA·Filed 2015·Granted Sep 4, 2018·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Guillaume Dutheuil files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →